ResMed has officially opened its new technology R&D facility in Sandyford in Dublin, and plans to create 70 new jobs in Ireland over the next four years.
The San Diego-headquartered global digital health company is investing €30m in R&D here.
It said it plans to double its Ireland-based software and technology team to support innovation, technology development, and product development, including roles such as mobile, AWS, and full-stack software developers, and algorithm/machine learning engineers.
ResMed specialises in medical products to combat sleep and respiratory disorders.
It focuses on technology using sensors to manage patients with chronic diseases in their homes.
The investment is supported by the Irish Government through IDA Ireland.
"These 70 new jobs, which ResMed is creating over the next four years, alongside a commitment of €30 million investment in research and development is really welcome," said Tánaiste and Minister for Enterprise, Trade and Employment Leo Varadkar.
"Ireland has become recognised globally for the talent of our workforce, especially in the area of healthcare technology and medical devices," he added.
Mick Farrell, CEO of ResMed, said this latest investment will support the continued growth of RedMed's product portfolio to meet the needs of patients across Ireland, Europe and the world.
"It will also create new capabilities and skills within our expanding team in Ireland and support our global innovation strategy," he added.
Mary Buckley, Executive Director of IDA Ireland said continued investment in the area of research and development is central to IDA Ireland's strategy 'Driving Recovery and Sustainable Growth 2021-2024’.
"This investment by ResMed is very welcome and demonstrates the company’s commitment to Ireland," she said.
"It is also an endorsement of the talented team in Dublin who have won this R&D mandate due to their track record in delivering innovative solutions," she added.
